Siste oppdateringer

ikke-malign 037-038 og 039-40 TAK-079-3001 Mezagitamab/placebo eller mezagitamab ved IgA-nefropati (IgAN)

BELANTAMABMAFODOTIN

Gyn 139 RAINFOL-OV2 Gemcitabin

Gyn 138 RAINFOL-OV2 Doksorubicin liposomal

Gyn 137 RAINFOL-OV2 Topotekan

Gyn 136 RAINFOL-OV2 Paklitaksel

Gyn 135abc RAINFOL-OV2 Rinatabartsesutekan

Ped CNS 003 HIT 2000 Metotreksat 5 g/m2/vinkristin SKK

Felles 126 IMPRESS Daktinomycin

Ped ALL 014abcd A2G/IntReALL/EsPhALL cytarabin 75 mg/m2

Sarkom 001 Euroboss1 IFO/CDP Cisplatin/ifosfamid

Blod 569-570 Belantamabmafodotin/ bortezomib BVd

Blod 567-568 Belantamabmafodotin/ pomalidomid BPd

Blod 396b, 397b Modakafusp 120 / 240 mg

Blod 567-568 Belantamabmafodotin/ pomalidomid BPd

Blod 569-570 Belantamabmafodotin/ bortezomib BVd

Blod 571ab ISB 2001-101. ISB 2001 kohort D

Ped ALL 048 IntReALL 2020 SCB 3+4 konsolidering uke 19-20/31-32, cytarabin/etoposid/syklofosfamid

Ped CNS 081ab LOGGIC/FIREFLY-2 Vinblastin

Ped CNS 079, 079ab, 080ab LOGGIC/FIREFLY-2 karboplatin/vinkristin

Ped lymfom 067 B-NHL IKKE STUDIE CC Cytara/deks/eto/vindesin/it trippel

Ped lymfom 064ab B-NHL rituksimab  1 mg/ml, 1 eller 2 dager

Ped lymfom 063 B-NHL syklofosfamid prefase etter rituksimab/trippel i.t.

Ped nyre 008ab-009 UMBRELLA Wilms/CCSK Vinkristin/daktino/doksorubicin

ØNH 027ab Cisplatin/fluorouracil/pembrolizumab

Sarkom 015, 016, 017 Ifosfamid 15g/10 g/12 g

Lymfom 241-244 Epkoritamab

Gyn 140 TroFuse-033 Pembrolizumab/paklitaksel/ karboplatin AUC5

Melanom 056, 057 EIK 1001/placebo + pembrolizumab

Gyn 142 TroFuse-033 Pembrolizumab 200 mg

Gyn 141abc TroFuse-033 Pembrolizumab/Sac-TMT div.

Urologi 026 EMA-CO, daktinomycin/etoposid/metotreksat/syklofosfamid/vinkristin

Blod 538 Holistic study. Rituksimab fast dose 1000 mg

Blod 315ab, 316ab AML/FLAG-Ida-venetoklaks

Ped ALL 029aa/bb/140a, med delkurer 029a-d/140bc. Interfant-21 Induksjon 1, dag 8-22

Ped ALL 034a-h/145ab/146 Interfant-21 OCTADA(D) del 1

Gyn 146 DESTINY-Endom01 Arm C Pembrolizumab 400 mg vedlikehold

Gyn 145 DESTINY-Endom01 Arm C KarboAUC5/pakli/pembro 200 mg

Gyn 144 DESTINY-Endomet01 Arm B Pembrolizumab/trastuzumab derux

Gyn 143 DESTINY-Endomet01 Arm A Rilvegostomig/trastuzumab derux

Blod 549-552 EMN37 Kohort 1 Dara/teklistamab (Tec-Dara)

Blod 368-370ab MagnetisMM-7 Arm C. Elranatamab Amendment 8

Ped ALL 090 A2G blokk C, Cytara/flu/idarub/mtx it/pegasp 6mnd+

Ped CNS 071ab HRMB induksjon etoposid(fosfat)/karboplatin

Ped ALL 089 A2G blokk B, cytarabin/metotreksat/pegaspargase/vinkristin

Blod 368-370ab MAGNETISMM-7 Arm C. Elranatamab Amendment 8

Blod 443 DREAMM5 sub-stud. 7 Belantamabmafodotin 0,5 mg/kg kohort 1

Urologi 043, 062 M-VAC -28 -14 Nyresparende Døgn

Ped ALL 142ab Interfant-21 MAE cytarabin/etoposid(fosfat)/mitoksantron

Ped ALL 141ab Interfant-21 ADE cytarabin/daunorubicin/etoposid(fosfat)